Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Galera Therapeutics, Inc. | 10,823,610 | reported | 19 Apr 2024 | tx 28+3,712,809 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2024 | PURCHASE | Galera Therapeutics, Inc. | 150,000 | 0.17 USD | |
| 08 Feb 2024 | PURCHASE | Galera Therapeutics, Inc. | 150,000 | 0.17 USD | |
| 07 Feb 2024 | PURCHASE | Galera Therapeutics, Inc. | 25,000 | 0.17 USD | |
| 06 Feb 2024 | PURCHASE | Galera Therapeutics, Inc. | 25,000 | 0.20 USD | |
| 05 Feb 2024 | PURCHASE | Galera Therapeutics, Inc. | 97,402 | 0.18 USD | |
| 30 Jan 2024 | PURCHASE | Galera Therapeutics, Inc. | 335,000 | 0.18 USD | |
| 29 Jan 2024 | PURCHASE | Galera Therapeutics, Inc. | 150,000 | 0.18 USD | first after silence |
1 purchase reported after at least 12 months of silence — most recent on 29 Jan 2024.